跳转到主要内容

Featured Review: Interventions to reduce Staphylococcus aureus in the management of eczema

This news item is more than 5 years old.
Image

In this interview with review author Anjna Rani we learn more about the recently published review, Interventions to reduce Staphylococcus aureus in the management of eczema.

Tell us about this Cochrane Review  
This review looks at the evidence of treatments, such as antibiotics, antibacterial soaps/baths, to reduce a type of bacteria called Staphylococcus aureus (S. aureus) that is predominant on skin with eczema.  The review assessed a wide variety of treatments to help treat/reduce infected eczema – 41 studies involving 1753 participants were included in total.

Why is it important for patients with eczema?
Eczema is a frustrating skin condition with a number of different treatments. It is important for patients with eczema to understand the variety of treatments available and which one(s) would be suitable for them and are more likely to work to reduce impact on everyday life.

What can this review tell us about how effective treatments are to reduce skin infections in the management of eczema?  
Topical corticosteroid/antibiotic combinations are still prescribed widely due to effective marketing. Antiseptic wash products are also widely used, and antibiotics prescribed readily for “infected” eczema when what is needed is adequate control of skin inflammation.  Unfortunately, however, despite the number of trials included, there was so much variance in the types of treatment that the quality of evidence is low

引用的多媒体源缺失,需要重新嵌入。


How does this review link to a James Lind Alliance priority topic? (This is a shared priority, important to patients and health professionals.)
This was one of the top 10 questions, actually grouped in the health professional priorities, - “How effective are interventions to reduce skin infections in the management of eczema?”

Does the review point to more research being needed?
The conclusion of the review, “In view of the low quality of evidence and lack of information on quality of life and antibiotic resistance, a larger, definitive trial on steroid/antibiotic combination treatment is required. With the increased concerns about antibiotic resistance, other strategies to treat S. aureus infection that do not involve antibiotics should be further investigated.” 

我们的Cookie使用

我们使用必要的cookie来使我们的网站工作。我们还希望设置可选的分析cookie,以帮助我们进行改进。除非您启用它们,否则我们不会设置可选的cookie。使用此工具将在您的设备上设置一个cookie来记住您的偏好。您随时可以随时通过单击每个页面页脚中的“Cookies设置”链接来更改您的Cookie首选项。
有关我们使用cookie的更多详细信息,请参阅我们的Cookies页面

接受全部
配置